Cardiothoracic & vascular anesthesia

Ultrasound‐guided supraclavicular cannulation of left brachiocephalic versus right internal jugular vein: Comparative analysis of central venous catheter‐associated complications

Paediatr AnaesthPublished Retrospective cohort study

Main finding · All complicationsResult — go to the resultOdds ratio 1.16 CI 0.64–2.07

Authors' conclusion

Among children undergoing cardiac surgery, there is no significant difference between the supraclavicular approach to the left brachiocephalic vein and the right internal jugular vein regarding complications.

Study context

Population
Children receiving central venous catheters for cardiac surgery over a two-year periodcatheters analysed (504 identified)
Participants
480 children
Exposure
Left brachiocephalic vein vs Right internal jugular vein
Outcome
Frequency of central venous catheter-associated complications (chylothorax, deep vein thrombosis, sepsis, or delayed chest closure)
Methodological detailssingle-centre, tertiary care university hospital
  • Single-centre
  • Tertiary care university hospital

Main finding

All complications

Odds ratio

1.16

CI 0.64–2.07

By group

Left brachiocephalic vein vs Right internal jugular vein
OR 1.16 (CI 0.64–2.07)

As reported in the abstract

Overall complications, all catheters
68/480 (14.2%)

Observational data: associations, not effects.

Secondary outcomes

Deviation from optimal insertion depth (height-based formula) · spread printed as ±; kind not named

Safety

OutcomeLeft brachiocephalic veinRight internal jugular veinOR (CI)
Chylothorax7.7%8.6%0.89 (0.39–1.91)
Thrombosis5.6%4.5%1.28 (0.46–3.31)

Original publication

Ultrasound‐guided supraclavicular cannulation of left brachiocephalic versus right internal jugular vein: Comparative analysis of central venous catheter‐associated complications. Paediatr Anaesth. Published 18 November 2022. doi:10.1111/pan.14600

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.